We only have this paper's title and publication details.
Read it at the sourceThis investigation reveals anti-PLA2R antibodies can guide therapeutic decisions and predict remission in membranous nephropathy, suggesting their clinical utility.
Anti-PLA2R antibodies: implications for therapeutic planning and the prediction of remission
No takes yet. Share an insight, caveat, or question.
Kirsztajn et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: